~~<i id='7E79A2DA02'><strike id='7E79A2DA02'><tt id='7E79A2DA02'><pre id='7E79A2DA02'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：Wikipedia 2025-10-01 00:52:41 - browse：16962

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Microsoft launches AI tool for clinical documentation through Epic

entertainment

hotspot

explore

Wikipedia

focus

JamesSulzerwithhisdaughterLivie.LindsaySulzerInthespringof2020,myalmost4-year-olddaughterLiviesustai

WSS

The perfect storm of weather conditions that led to the devastating wildfires in Maui

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Pumping milk in bathrooms at health conferences is common

HPV vaccine, cervical cancer study delivers historic results

Medicare drug price lawsuits could be good politics for Biden

FDA endorses new sterilization method for medical devices

hotspot

leisure time

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

Pumping milk in bathrooms at health conferences is common

Medicare details structure of new drug price negotiation program

Pumping milk in bathrooms at health conferences is common

Medical records are filled with copy

FDA sets aggressive timeline for overhauling inspection procedures

Cancer drug shortages should be causing more outrage

Listen: Your guide to Wegovy's blockbuster heart study

After affirmative action ruling, medical educators look to 'holistic review'

Update the Apgar Score to remove skin color

hotspot

Genentech weighs delaying cancer therapy after drug pricing law

Prior authorization reform is both possible and imperative

A pediatrician calls for Congress to pass the child tax credit deal

Prior authorization reform is both possible and imperative

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

High breast density mammograms need follow

explore

Wikipedia

focus

focus